- Publications
- Influence
Share This Author
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
- J. Mcconnell, C. Roehrborn, Joseph A. Smith
- MedicineThe New England journal of medicine
- 18 December 2003
TLDR
Update on AUA guideline on the management of benign prostatic hyperplasia.
- K. McVary, C. Roehrborn, John T. Wei
- MedicineThe Journal of urology
- 1 May 2011
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
- A. Stephenson, P. Scardino, A. Pollack
- MedicineJournal of clinical oncology : official journal…
- 20 May 2007
TLDR
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
- C. Roehrborn, P. Siami, F. Montorsi
- MedicineEuropean urology
- 2010
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.
- M. Hall, S. Womack, A. Sagalowsky, T. Carmody, M. D. Erickstad, C. Roehrborn
- MedicineUrology
- 1 October 1998
Radical prostatectomy versus observation for localized prostate cancer.
- T. Wilt, M. Brawer, T. Wheeler
- MedicineThe New England journal of medicine
- 18 July 2012
TLDR
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.
- C. Roehrborn, P. Boyle, J. Nickel, K. Hoefner, G. Andriole
- MedicineUrology
- 1 September 2002
The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.
- J. Nickel, C. Roehrborn, M. O'Leary, D. Bostwick, M. Somerville, R. Rittmaster
- MedicineEuropean urology
- 1 December 2008
Benign prostatic hyperplasia: an overview.
- C. Roehrborn
- MedicineReviews in urology
- 2005
TLDR
...
...